Structure-activity relationships of ketolides vs. macrolides

Clinical Microbiology and Infection

Volumn 7, Issue SUPPL. 3, 2001, Pages 11-17

  Douthwaite, S ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; KETOLIDE; MACROLIDE; TELITHROMYCIN;

CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVIEW; RIBOSOME; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; HUMANS; KETOLIDES; MACROLIDES; MOLECULAR SEQUENCE DATA; RIBOSOMES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035224671     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2001.00049.x     Document Type: Article

References (10)

1. Jones WR, Nichols RL, Finland M. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandromycin and streptogramin. Proc Six Exp Biol Med 1956; 93: 388-93.
2. Neu HC. The development of macrolides: clarithromycin in perspective. J Antimicrob Chemother 1991; 27 (Suppl. 4): 1-9.
3. Bahal N, Nahata MC. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. Ann Pharmacother 1992; 26: 46-55.
4. Piscitelli SC, Danziger LH, Rod void KA. Clarithromycin and azithromycin: new macrolide antibiotics. Clin Pharm 1992; 11: 137-52.
5. Bryskier AJ, Brutzler JP, Neu HC, Tulkens PM, eds. Macrolides: Chemistry, pharmacology and clinical uses. Paris: Arnette Blackwell, 1993.
6. Somogyi AA, Bochner F, Hetzel D, Williams DB. Evaluation of the intestinal absorption of erythromycin in man: Absolute bioavailability and comparison with enteric coated erythromycin. Pharm Res 1995; 12: 149-55.
7. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Int Med 1990; 150: 1881-4.
8. B resistance phenotype. J Antimicrob Chemother 1997; 40: 85-90.
9. Agouridas C, Benedetti Y, Bonnefoy A et al. Ketolides: a new class of macrolide antibacterials - structural characteristics and biological properties of RU 64004. Curr Infect Dis Ther 1997; 21: 279-95.
10. Hansen HL, Mauvais P, Douthwaite S. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol Microbiol 1999; 31: 623-31.